Pregnancy :: Elevated autoantibodies linked to preeclampsia

Women who develop preeclampsia during pregnancy are more likely to develop certain dangerous autoantibodies than women with normal pregnancies, and these autoantibodies are still present two years after childbirth in about 20 percent of women who had the disorder, scientists from the University of Pittsburgh report in the March issue of Hypertension, the journal of the American Heart Association.

Obesity :: Obesity high among Baltimore’s homeless

A small but telling study from the Johns Hopkins Children?s Center reveals an ominous trend: more than expected, obesity shadows Baltimore?s homeless children and their caregivers, putting them at high risk for heart disease, stroke and type 2 diabetes, among other conditions.

Heart Disease :: Parents who live long pass on lower risk of cardiovascular disease

Researchers from the long-standing Framingham Heart Study (FHS), a program of the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health, report that people whose parents live longer were more likely to avoid developing high blood pressure, high cholesterol, and other risk factors for cardiovascular disease in middle age than their peers whose parents died younger. They also found that the risk factor advantages persisted over time.

Sleep :: FDA requests label change for all sleep disorder drugs

The U.S. Food and Drug Administration (FDA) has requested that all manufacturers of sedative-hypnotic drug products, a class of drugs used to induce and/or maintain sleep, strengthen their product labeling to include stronger language concerning potential risks.

HIV :: AIDS Healthcare reacts on Abbott’s ban on HIV drugs to Thailand

AIDS Healthcare Foundation (AHF), the US? largest HIV/AIDS healthcare and prevention and education provider, which operates free AIDS treatment clinics in the US, Africa, Latin America/Caribbean and Asia, today excoriated US drug giant, Abbott Laboratories for its heartless decision to blacklist the country of Thailand by withdrawing its new drugs? applications from that country?s government review process?a move which in essence deprives Thailand and its citizens of access to any new Abbott medications.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack